| Integrated_Biologics_Research_Laboratories The use of zwitterionic technology to treat disease. Research and development of new therapeutic modalities for cancer, immunology and infectious disease. |
| InterMune_Pharmaceuticals Develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. |
| IPRC-International_Pharmaceutical_Research_Center Jordan based pharmaceutical research center, offer services including clinical service, bioanalysis service, data management, quality assurance. |
| Isis_Pharmaceuticals,_Inc_ Biomedical pharmaceutical company working on new treatments for Crohn's Disease. |
| Jurilab_Ltd_ Company in genetic discovery producing drug targets and DNA chips. |
| Karo_Bio_AB A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development. |
| Kinex_Pharmaceuticals Drug discovery and development company that is focused on next generation anti-cancer drugs. |
| Kinship Provides development and support services to pharmaceutical firms and contract research organizations. |
| LMD_Pharmacognosie A discovery company combining scientific investigation of traditional plant-based remedies and latest scientific technology to offer novel bioactive molecules to the pharmaceutical, cosmeceutical, nut |
| Maas_BiolAB_LLC Developing treatments for CNS disease. |
| Maelor_Pharmaceuticals,_Ltd_ Development and licencing out of novel presentations of off-patent generic pharmaceuticals and medical devices. Specialising in the fields of urology, intravenous fluids, woundcare and anaesthesia in |
| MDL_Information_Systems,_Inc_ MDL is a leading provider of integrated logistics and decision support systems that enable a high-throughput environment for research and development in the life sciences and chemical industries. |
| Metabolic_Solutions,_Inc_ Services in support of Erythromycin Breath Test and mass spectrometry service for measuring stable isotopes. |
| Monogram_Biosciences Develops and markets innovative products to guide and improve treatment of viral diseases. (Nasdaq: MGRM). |
| Mountain_View_Pharmaceuticals,_Inc_ Leader in the biopharmaceutical drug delivery field, with technology of apply its polymer coupling technology platforms and advanced analytical methods. |
| Mpex_Pharmaceuticals,_Inc_ Specializes in combining inhibitors of bacterial resistance with proven antibiotics to treat serious infections. Based in San Diego, California. |
| Myriad_Pharmaceuticals Biopharmaceutical company focused on the development of therapeutic and diagnostic products using genomic and proteomic technologies. Services include drug discovery, gene discovery and genetic testin |
| Nanobac_Life_Sciences Research, diagnostics and pharmaceutical development related to nanobacterial infectious disease. |
| Nanotherapeutics,_Inc_ A company focuses on developing nano-scale inhaled, nasal, injectable, and oral delivery systems for improved drug therapies base Alachua, Florida |
| NCE_Development_-_Dr_Reddy\'s Dr Reddy's custom pharmaceutical services provides medicinal chemistry, process R & D and CGMP scale-up, formulation development and CGMP scale-up for clinical trials. |
| Neurochem_Inc_ Researches and develops compounds that inhibit the formation, deposition and toxic effects of amyloid fibrils within the body. |
| NeuroTargets_Ltd_ Discovery and marketing of medications for inflammation and neuropathic pain. Features company profile and details of technology platform. Guildford, Surrey, United Kingdom. |
| Neurotech_Co_,_Ltd_ Neurotech Pharmaceuticals, founded in Apr.1998, aims to develop and invent Novel lead compounds that will threaten diseases associated with brain disorders and mal-functional retardances. |
| Novartis_Ophthalmics_Canada A global leader in research, development and manufacturing of innovative ophthalmic pharmaceuticals that assist in the treatment diseases and disorders of the eye. |
| Novirio_Pharmaceuticals_Limited A independent biopharmaceutical company engaged in the discovery and development of pharmaceuticals for the treatment of life threatening human viral diseases. |
| NovoBiotic_Pharmaceuticals_LLC_ Antibiotic discovery, using proprietary technology as a platform, for growing previously unculturable microorganisms in the laboratory. Includes publications, related news, and careers in Cambridge, M |
| Novogen_Ltd_ Discovers, develops, manufactures and markets isoflavonoids for menopausal non-prescription drugs, and multiple signal transduction regulator drugs for cancer. Includes technological overview, and his |
| Oasmia_Pharmaceutical Development of techniques to focus the release of cytostatics to tumour tissue based in Uppsala, Sweden. |
| Oculus_Innovative_Sciences Developer of Microcyn 60 disinfectant, L3 oncology compound and drug-eluting stents along with other disruptive health care technologies. |
| Oncopharm_Corporation Involved in research, development and production of new antileukemic drugs. |
| Oridis_Biomed A research-oriented biotechnology company gaining new insights into ORIgins of DISeases with genomic and proteomic investigation of human diseased tissues. The company will develop new diagnostic and |
| Oscient_Pharmaceuticals Develops and markets new compounds including antibiotics. Features investor information and product details. Waltham, Massachusetts, USA. |
| Palumed_S_A_ Pharmaceutical company developing novel antimalarial drugs candidates against resistant strains of Plasmodium falciparum. |
| Paragon_BioServices,_Inc_ A contract research organization providing products and research services in molecular biology, cell culture, biochemistry, and molecular histology to accelerate each client's drug discovery and precl |
| Perry_Scientific,_Inc_ A full service contract research organization, a member of AALAS following AAALAC and NIH guidelines. We can supply all the services you need for drug development; from in vitro screening through prec |
| Pharmaceutica_Limited Site contains overview of new anti-infective technology developed by the company and problems of drug resistance in general. Bacterial Transforming Agents change antibiotic-resistant bacteria, e.g. MR |
| Pharmaceutics_International,_Inc_ Core business is formulation development together with clinical trial material manufacturing and commercial manufacture of low volume products. |
| Pharmacopeia_Online Provider of products and services that accelerate drug discovery and chemical development. |
| Pherin_Pharmaceutical Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment of central nervous system and neuroendocrine system diso |
| Phytopharm_plc_Botanical_Research_Company As the world's leading company focus on the research and development of novel pharmaceutical and functional food products based on clinical and pre-clinical data generated from medicinal plant extract |
Home
Site Map
Contact Us
Search
Submit Button
document.getElementById('initialnav').style.display = 'none';
About Us
About Us Home
Management
Corporate Overview
Our Locations
Corporate Giving & Grants
Strategic Alliances
Views on Public Policy
Diversity
Sustainability
Supplier Relations
Alumni Network
Research
Research Home
Our Vision
Focus Areas
Science of Biotechnology
Scientist Profiles
Postdoctoral Program
Scientific Resource Board
Development
Development Home
Development Pipeline
Medicine Development
Clinical Trials
Clinical Fellowships
Medicines
Medicines Home
Product Information
Approvals Timeline
Disease Education
Patient Access Programs
Patient Profiles
Investors
Investors Home
Calendar of Events
Contacts
Corporate Governance
E-Delivery of Annual Report
E-Mail Alerts
Investor Fact Sheet
FAQs
Financials
Literature Requests
SEC Filings
Stock Information
Media
Media Home
Press Releases
Media Kits
Media Inquiries
News Subscription Service
Careers
Careers Home
Job Postings
University Recruiting
Culture
Benefits
National Conferences
Connect With a Recruiter
var so = new SWFObject("/gene/cmn/swf/home.swf?dataPath=/gene/cmn/swf/xml/homepage.xml&cssPath=/gene/cmn/swf/gene_flash.css","Home", "100%", "100%", "7", "#648c96"); so.addParam("wmode", "opaque"); so.addParam("scale", "noscale"); so.addParam("menu", "false"); so.addVariable("pid",getQueryParamValue("pid")); so.setAttribute("bgImage","/gene/cmn/swf/images/bg/patients/Home.jpg"); so.write("flashcontent");
2008 Holiday Giving Programs This year, Genentech's various holiday giving programs are helping employees give back to their communities.
function prRotateNews (){} SCIENTIFIC LEADERSHIP >> 
Genentech's scientists are some of the most prolific in the industry and in their fields. 
Genentech's pipeline continues to grow, with more than 100 promising projects in development. Patient Access >>
Genentech is committed to making sure price is not a barrier to access for patients.Roche Proposal >>August 21, 2008 8-K filingAugust 13, 2008 press releaseJuly 24, 2008 press releaseJuly 21, 2008 press releaseAvastin Dear Healthcare Provider Letter >>Genentech has issued a Dear Healthcare Provider Letter for Avastin® (bevacizumab) in ocular use.
Privacy Policy |
Terms & Conditions
O_GoT('Feedback');
O_GoT('Very Poor');
O_GoT('Poor');
O_GoT('Fair');
O_GoT('Good');
O_GoT('Very Good');
© Genentech, Inc.
